← Leaderboards
George W. Vetrovec
Virginia Commonwealth University
$8,090
Attributed
$8,090
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$8,090 · 3
By mechanism
M01$8,090 · 3
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Gea-Ny Tseng$8,971,144
- Harry P Selker$168,560,770
- Billy R Martin$6,338,294
- William Gregory Hundley$19,718,962
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationCoronary DisorderHuman MortalityMyocardial InfarctionClinical ResearchHeart Disorder ChemotherapyHuman SubjectClinical TrialsHeart VentricleHeart PharmacologyCardiovascular PharmacologyPeptidyl Dipeptidase ACoronary ArteryDisease /Disorder Proneness /RiskCardiovascular Disorder ChemotherapyEnzyme InhibitorsHeart FunctionDiureticsAlpha Adrenergic AgentAntihypertensive AgentsCalcium Channel BlockersCardiovascular Disorder PreventionAce InhibitorsLipogenesis Inhibitor
Grant awards (5)
Prevention of Events with Angiotensin Converting Enzyme Inhibition$6,794
M01 · FY2004 · RR
ANTIHYPERTENSIVE AND LIPID LOWERING TREATMENT TO PREVENT HEART ATTACK$0
M01 · FY2001 · RR
PREVENTION OF EVENTS WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS$0
M01 · FY2001 · RR
ANTIHYPERTENSIVE AND LIPID LOWERING TREATMENT TO PREVENT HEART ATTACK$648
M01 · FY2000 · RR
PREVENTION OF EVENTS WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS$648
M01 · FY2000 · RR